Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Industrial health research in Canada

Yves Morin
CMAJ June 05, 2007 176 (12) 1734-1734-a; DOI: https://doi.org/10.1503/cmaj.1060190
Yves Morin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2007 Canadian Medical Association or its licensors

In his commentary on the pharmaceutical industry, Henry Mintzberg recommends several measures that are already in place in Canada.1 He recommends firmer regulation of pricing, but Canada is unique in that it has 2 levels of price control, at the federal and provincial levels. He also recommends independent clearing houses for information on health products, but Canada already has a plethora of these at the federal and provincial levels, in addition to scientific bodies and journals. In addition, he suggests that direct-to-consumer advertising should be stopped, but it is currently forbidden in Canada.

A more important issue, in my opinion, is the unimpressive condition of industrial health research in Canada. Although we have the third-largest number of biotechnology companies in the world after the United States and the United Kingdom, our country is at the bottom of the Organisation for Economic Co-operation and Development's ranking for industrial health research and development.

Unfortunately, Canadian discoveries are often developed elsewhere. Instead of blaming the pharmaceutical industry for developing and commercializing health products discovered by biotechnology companies, we should establish conditions that will convince them to do this work in Canada. Instead of finding fault with intellectual property regulations as they apply to novel health products, we should see that they are strengthened in Canada. Instead of taking issue with the pharmaceutical industry's research priorities (saying, for example, that industry should study the causes of breast cancer and not its cures), we should make sure that the environment in Canada encourages industrial research and development. Instead of lamenting the increasing numbers of health researchers in industry, we should boost the inappropriately small number of people doing industrial health research in Canada.

Mintzberg is world-renowned for his studies in management and strategic planning. He should now focus on developing a genuine pharmaceutical strategy for Canada: this must be a priority for our health care delivery system.

REFERENCE

  1. 1.↵
    Mintzberg H. Patent nonsense: Evidence tells of an industry out of social control. CMAJ 2006;175(4):374-6.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 176 (12)
CMAJ
Vol. 176, Issue 12
5 Jun 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Industrial health research in Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Industrial health research in Canada
Yves Morin
CMAJ Jun 2007, 176 (12) 1734-1734-a; DOI: 10.1503/cmaj.1060190

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Industrial health research in Canada
Yves Morin
CMAJ Jun 2007, 176 (12) 1734-1734-a; DOI: 10.1503/cmaj.1060190
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • REFERENCE
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Highlighting obesity as a risk factor for endometrial cancer
  • Hepatitis B vaccination for Canadian children: time for an adult conversation
  • Codesigning a public health approach to preventing firearm-related suicide deaths with rural communities
Show more Letters

Similar Articles

Collections

  • Topics
    • Drug regulation

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire